Methods for the early diagnosis of ovarian cancer

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000, C530S328000, C530S324000

Reexamination Certificate

active

06870027

ABSTRACT:
The disclosed nucleic acid primer sets, used in combination with quantitative amplification (PCR) of tissue cDNA, can indicate the presence of specific proteases in a tissue sample. Specifically, the present invention relates to expression of PUMP-1 protease (matrix metalloprotease 7). The detected proteases are themselves specifically over-expressed in certain cancers, and their presence may serve for early detection of associated ovarian and other malignancies, and for the design of interactive therapies for cancer treatment.

REFERENCES:
Bowie et al (Science, 1990,247:1306-1310).*
Akizawa et al (Peptide Chemistry, 1995, 33:305-308).*
Harlow and Lane, (Antibodies, A Laboratory Manual, 1988, Cold Spring Harbor Laboratory, New York, pp. 96-97).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for the early diagnosis of ovarian cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the early diagnosis of ovarian cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the early diagnosis of ovarian cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3447488

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.